Using Metaphors to Explain Molecular Testing to Cancer Patients
- PMID: 28220022
- PMCID: PMC5388373
- DOI: 10.1634/theoncologist.2016-0270
Using Metaphors to Explain Molecular Testing to Cancer Patients
Abstract
Background: Molecular testing to identify targetable molecular alterations is routine practice for several types of cancer. Explaining the underlying molecular concepts can be difficult, and metaphors historically have been used in medicine to provide a common language between physicians and patients. Although previous studies have highlighted the use and effectiveness of metaphors to help explain germline genetic concepts to the general public, this study is the first to describe the use of metaphors to explain molecular testing to cancer patients in the clinical setting.
Methods: Oncologist-patient conversations about molecular testing were recorded, transcribed verbatim, and coded. If a metaphor was used, patients were asked to explain it and assess its helpfulness.
Results: Sixty-six patients participated. Nine oncologists used metaphors to describe molecular testing; 25 of 66 (38%) participants heard a metaphor, 13 of 25 (52%) were questioned, 11 of 13 (85%) demonstrated understanding and reported the metaphor as being useful. Seventeen metaphors (bus driver, boss, switch, battery, circuit, broken light switch, gas pedal, key turning off an engine, key opening a lock, food for growth, satellite and antenna, interstate, alternate circuit, traffic jam, blueprint, room names, Florida citrus) were used to explain eight molecular testing terms (driver mutations, targeted therapy, hormones, receptors, resistance, exon specificity, genes, and cancer signatures).
Conclusion: Because metaphors have proven to be a useful communication tool in other settings, these 17 metaphors may be useful for oncologists to adapt to their own setting to explain molecular testing terms. The Oncologist 2017;22:445-449Implications for Practice: This article provides a snapshot of 17 metaphors that proved useful in describing 8 complicated molecular testing terms at 3 sites. As complex tumor sequencing becomes standard of care in clinics and widely used in clinical research, the use of metaphors may prove a useful communication tool, as it has in other settings. Although this study had a small sample, almost all of the patients who were exposed to metaphors in explaining molecular testing reported it as being helpful to their understanding. These 17 metaphors are examples of potentially useful communication tools that oncologists can adapt to their own practice.
Keywords: Communication; Comprehension; Metaphor; Molecular sequencing; Physician‐patient relationship.
© AlphaMed Press 2017.
Conflict of interest statement
Similar articles
-
Can metaphors and analogies improve communication with seriously ill patients?J Palliat Med. 2010 Mar;13(3):255-60. doi: 10.1089/jpm.2009.0221. J Palliat Med. 2010. PMID: 19922170 Free PMC article.
-
Serious Illness Conversations: Paving the Road with Metaphors.Oncologist. 2018 Jun;23(6):730-733. doi: 10.1634/theoncologist.2017-0448. Epub 2018 Jan 25. Oncologist. 2018. PMID: 29371478 Free PMC article.
-
[Images of cancer: metaphors in the literature].Ned Tijdschr Geneeskd. 2011;155(45):A4178. Ned Tijdschr Geneeskd. 2011. PMID: 22085582 Dutch.
-
Use of metaphor in provider-patient communication in medical settings: A systematic review.Patient Educ Couns. 2025 Aug;137:109184. doi: 10.1016/j.pec.2025.109184. Epub 2025 May 22. Patient Educ Couns. 2025. PMID: 40446612 Review.
-
Perspectives on the insidious nature of pain metaphor: we literally need to change our metaphors.Front Pain Res (Lausanne). 2023 Sep 15;4:1224139. doi: 10.3389/fpain.2023.1224139. eCollection 2023. Front Pain Res (Lausanne). 2023. PMID: 37781218 Free PMC article. Review.
Cited by
-
Physician Communication and Patient Understanding of Molecular Testing Terminology.Oncologist. 2021 Nov;26(11):934-940. doi: 10.1002/onco.13930. Epub 2021 Aug 24. Oncologist. 2021. PMID: 34369626 Free PMC article.
-
Understanding Immunotherapy Terminology: An Analysis of Provider-Patient Conversations.Immunomedicine. 2021 Dec;1(2):e1028. doi: 10.1002/imed.1028. Epub 2021 Sep 2. Immunomedicine. 2021. PMID: 34901734 Free PMC article.
-
Multilevel Influences on Patient-Oncologist Communication about Genomic Test Results: Oncologist Perspectives.J Health Commun. 2018;23(7):679-686. doi: 10.1080/10810730.2018.1506836. Epub 2018 Aug 21. J Health Commun. 2018. PMID: 30130477 Free PMC article.
-
A mixed-method analysis of oncologist-patient communications about immune checkpoint inhibitors (COACH).Oncologist. 2025 Jul 4;30(7):oyaf064. doi: 10.1093/oncolo/oyaf064. Oncologist. 2025. PMID: 40622009 Free PMC article.
References
-
- Blanchette PS, Spreafico A, Miller FA et al. Genomic testing in cancer: Patient knowledge, attitudes, and expectations. Cancer 2014;120:3066–3073. - PubMed
-
- Brown RF, Butow P, Butt DG, Moore A, Tattersall MH. Developing ethical strategies to assist oncologist in seeking informed consent to cancer clinical trials. Soc Sci Med 2004;58:379–390. - PubMed
-
- Albrecht TL, Ruckdeschel JC, Riddle JC et al. Communication and decision making about cancer clinical trials. Patient Educ Counsel 2003;50:39–42. - PubMed
-
- Fallowfield L, Jenkins V, Farewell V et al. Efficacy of a cancer research UK communication skills training model for oncologists: A randomised controlled trial. Lancet 2002;359:650–656. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials